Novel 6-aminofuro[3,2-c]pyridines as potent, orally efficacious inhibitors of cMET and RON kinases von Steinig, Arno G., Li, An-Hu, Wang, Jing, Chen, Xin, Dong, Hanqing, Ferraro, Caterina, Jin, Meizhong, Kadalbajoo, Mridula, Kleinberg, Andrew, Stolz, Kathryn M., Tavares-Greco, Paula A., Wang, Ti, Albertella, Mark R., Peng, Yue, Crew, Linda, Kahler, Jennifer, Kan, Julie, Schulz, Ryan, Cooke, Andy, Bittner, Mark, Turton, Roy W., Franklin, Maryland, Gokhale, Prafulla, Landfair, Darla, Mantis, Christine, Workman, Jen, Wild, Robert, Pachter, Jonathan, Epstein, David, Mulvihill, Mark J.

Volltext

Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro von Bell, Carol, Lynam, Eric, Landfair, Darla J., Janjic, Nebojsa, Wiles, Marc E.

Volltext

Potent and selective cyclohexyl-derived imidazopyrazine insulin-like growth factor 1 receptor inhibitors with in vivo efficacy von Jin, Meizhong, Kleinberg, Andrew, Cooke, Andy, Gokhale, Prafulla C., Foreman, Kenneth, Dong, Hanqing, Siu, Kam W., Bittner, Mark A., Mulvihill, Kristen M., Yao, Yan, Landfair, Darla, O’Connor, Matthew, Mak, Gilda, Pachter, Jonathan A., Wild, Robert, Rosenfeld-Franklin, Maryland, Ji, Qunsheng, Mulvihill, Mark J.

Volltext

Abstract 3900: Discovery of FQIT: An imidazo[5,1- f ][1,2,4]triazine derived dual IGF-1R/IR inhibitor von Jin, Meizhong, Gokhale, Prafulla, Cooke, Andy, Foreman, Kenneth, Buck, Elizabeth, May, Earl, Feng, Lixing, Bittner, Mark, Kadalbajoo, Mridula, Landfair, Darla, Siu, Kam, Stolz, Kathryn, Werner, Douglas, Laufer, Radoslaw, Li, An-Hu, Dong, Hanqing, Steinig, Arno, Kleinberg, Andrew, Yao, Yan, Pachter, Jonathan, Wild, Robert, Mulvihill, Mark

Volltext

Abstract 2915: Discovery and characterization of OSI-296, a dual inhibitor of cMET and RON kinases von Steinig, Arno G., Li, An-Hu, Wang, Jing, Kleinberg, Andrew, Dong, Hanqing, Wang, Ti, Gavagan, Kathryn M. Stolz, Jin, Meizhong, Tavares-Greco, Paula, Peng, Yue, Kahler, Jen, Castaldo, Linda, McCormack, Siobhan, Kan, Julie, Albertella, Mark, Cooke, Andy, Turton, Roy, Bittner, Mark, Franklin, Maryland, Landfair, Darla, Gokhale, Prafulla, Wild, Robert, Pachter, Jonathan, Epstein, David, Mulvihill, Mark J.

Volltext

Abstract 4486: OSI-027, a selective dual mTORC1/TORC2 kinase inhibitor displays broad spectrum anti-tumor activity in preclinical models of human cancer von Gokhale, Prafulla C., Bhagwat, Shripad V., Crew, Andrew P., Cooke, Andrew, Mantis, Christine, Workman, Jennifer E., Landfair, Darla, Bittner, Mark, Epstein, David M., Pachter, Jonathan A., Wild, Robert

Volltext

Cellular Uptake of Liposomal Daunorubicin and the Induction of Apoptosis von Atherton Gray, Darla J. Landfair, Marc E. Wiles

Volltext

Camptothecin Analogue Efficacy In Vitro: Effect of Liposomal Encapsulation of GI147211C (NX211) von Eric Lynam, Darla J. Landfair, Marc E. Wiles

Volltext

Discovery of an Orally Efficacious Imidazo[5,1-f][1,2,4]triazine Dual Inhibitor of IGF-1R and IR von Jin, Meizhong, Gokhale, Prafulla C, Cooke, Andy, Foreman, Kenneth, Buck, Elizabeth, May, Earl W, Feng, Lixin, Bittner, Mark A, Kadalbajoo, Mridula, Landfair, Darla, Siu, Kam W, Stolz, Kathryn M, Werner, Douglas S, Laufer, Radoslaw S, Li, An-Hu, Dong, Hanqing, Steinig, Arno G, Kleinberg, Andrew, Yao, Yan, Pachter, Jonathan A, Wild, Robert, Mulvihill, Mark J

Volltext

Oligonucleotide NX1838 Inhibits$VEGF_{165}-Mediated$Cellular Responses in vitro von Bell, Carol, Eric Lynam, Darla J. Landfair, Nebojsa Janjic, Marc E. Wiles

Volltext

Oligonucleotide NX1838 inhibits VEGF165-mediated cellular responses in vitro von Bell, C, Lynam, E, Landfair, D J, Janjic, N, Wiles, M E

Volltext

Anthracycline Efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal Daunorubicin and Doxorubicin for Multiple Tumor Cell Types von Wiles, Marc E., Bell, Carol, Landfair, Darla, Lynam, Eric, Bendele, R. A.

Volltext